Open Position : Technician/ Engineer assistant


You will ensure the implementation, execution and analysis of biology experiments according to predefined protocols (cellular, molecular, and biochemistry) necessary for the successful completion of projects evaluation of the therapeutic activity of molecules and/or their mechanism of action. You will ensure the proper maintenance of a laboratory notebook. You will contribute to the management and maintenance of the laboratory and to the operational quality management. You will report to the BIO group headed by the company’s pharmacology of the company. You will be required to interact with the development teams of the development teams.


We are looking for a motivated, committed and curious person. The pre-requisites for this position are the following:

  • Cell culture and molecular biology are the key expertises of this position
  • Mastery of office automation tools (Pack Office) for the recording of results
  • Analysis of experimental data (GraphPad Prism, ImageJ, Pack Office…)
  • Teamwork (communicate, express yourself and be a good listener within the team)
  • Respect of hygiene and security rules
  • Respect and update of operational quality rules
  • Rigor and professional conscience
  • Autonomy and reactivity
  • Conscientious follow-up of a study protocol
  • Rigor and organization for the follow-up, maintenance and ordering of laboratory equipment and reagents
  • ≥ 2 years of professional experience
  • Mastery of analysis tools (GraphPad Prism, ImageJ, …)
  • Flow cytometry
  • Experience in the pharmaceutical industry or biotechnology

Desired diploma: Bac +2/3

Work contract: Immediate availability: fixed-term contract. Possibility of evolution into a permanent contract.

Candidate: Send into the same PDF File your Resume+Cover letter and 2 letters of reference

Excited to join our Team, write us directly just below!


Genoscience Pharma has announced a new agreement for research at the Hebrew University of Jerusalem on targeted degradation technology

| News | No Comments
MARSEILLE-JERUSALEM, April 19, 2023 – Genoscience Pharma a clinical-stage biopharmaceutical company that develops disruptive therapeutics for the treatment of cancer patients, announced today a new research agreement with Yissum Research…

J.P. Morgan Week – SAN FRANCISCO- 9 to 11 January 2023

| Events | No Comments
J.P. Morgan Healthcare Week 2023 We participated both to the French Healthcare Corner organized by Team France Export and Business France, and to the BIO’s One-on-One Partnering™ by the Biotechnology…

ODD obtained by Genoscience Pharma from FDA to treat HCC

| News | No Comments
Genoscience Pharma receives FDA Orphan Drug Designation for ezurpimtrostat to treat HepatoCellular Carcinoma (HCC) Ezurpimtrostat could meet important unmet need in HCC, bringing new treatment options to patients worldwide FDA…

Genoscience Pharma announces the start of GNS561’s Phase 2b Clinical Trial

| News | No Comments
Genoscience Pharma announces launch of phase 2b clinical trial of ezurpimtrostat (GNS561) to treat hepatocarcinoma in combination with an immune checkpoint inhibitor and an antiangiogenic agent First patient received initial…